Clear market notes built around the JSE, the rand, and what matters locally.

2026-08-06 13:15 • The Motley Fool Positive Axe Cap view: Selective

Berkshire Hathaway may have repurchased up to $11 billion of its own stock in the last quarter under CEO Greg Abel, signaling management's confidence that shares trade below intrinsic value. The massive buyback reflects Abel's disciplined capital allocation approach, similar to Warren Buffett's philosophy, prioritizing value over acquisitions. While positive for long-term shareholders, the buyback is a snapshot of management's valuation view rather than a guarantee of near-term stock gains.

Axe note: Greg Abel’s sizable share repurchase at Berkshire highlights disciplined capital use—something South African investors can learn from amid volatile rand conditions.

2026-08-06 13:10 • The Motley Fool Neutral Axe Cap view: Neutral

Peter R. Lane, Director at Goosehead Insurance, purchased 1,600 shares at $63.14 per share on July 31, 2026, totaling approximately $101,000. The purchase signals insider confidence despite the stock declining 32% over the past year. While the company has demonstrated strong revenue growth averaging 19% year-over-year, its P/E multiple of 49x remains elevated for the insurance sector.

Axe note: Director’s insider purchase conflicts with stretched valuation and weak share performance.

2026-08-06 12:30 • The Motley Fool Positive Axe Cap view: Selective

Arcutis Biotherapeutics CEO Todd Watanabe sold 4,375 shares for $114,275 on August 3, 2026, to cover tax withholding obligations on vesting restricted stock units. The sale is non-discretionary and does not signal a change in management sentiment. Meanwhile, Arcutis reported strong Q2 2026 results with its flagship product Zoryve generating $129.9 million in revenue (59% growth) and the company achieving profitability with $15 million net income. The company raised full-year guidance to $525-540 million and received FDA approval to expand Zoryve's indication to treat plaque psoriasis in children as young as age 2.

Axe note: Robust Q2 growth and profitability from Arcutis impress, but the South African market should watch USD/ZAR instead.